HIGHLIGHTS
- who: Alberto Falk Delgado from the Department of Surgical Sciences, Uppsala University, Uppsala, Sweden Clinical Neuroscience, Karolinska have published the research work: Outcome switching in randomized controlled oncology trials reporting on surrogate endpoints: a cross-sectional analysis, in the Journal: Scientific Reports Scientific Reports of 25/07/2017
- what: The aim of this study was to assess the prevalence of, and the factors associated with primary outcome switching among oncology trials reporting on a surrogate outcome.
- how: The authors hypothesized that outcome switching still occurs in oncology drug trials reporting on surrogate endpoints13 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.